A novel application of the Intent to Attend assessment to reduce bias due to missing data in a randomized controlled clinical trial

Dustin J. Rabideau, Andrew A. Nierenberg, Louisa G. Sylvia, Edward S. Friedman, Charles L. Bowden, Michael E. Thase, Terence A. Ketter, Michael J. Ostacher, Noreen Reilly-Harrington, Dan V. Iosifescu, Joseph R. Calabrese, Andrew C. Leon, David A. Schoenfeld

Research output: Contribution to journalArticlepeer-review

4 Scopus citations

Abstract

Background Missing data are unavoidable in most randomized controlled clinical trials, especially when measurements are taken repeatedly. If strong assumptions about the missing data are not accurate, crude statistical analyses are biased and can lead to false inferences. Furthermore, if we fail to measure all predictors of missing data, we may not be able to model the missing data process sufficiently. In longitudinal randomized trials, measuring a patient's intent to attend future study visits may help to address both of these problems. Leon et al. developed and included the Intent to Attend assessment in the Lithium Treatment - Moderate dose Use Study (LiTMUS), aiming to remove bias due to missing data from the primary study hypothesis. Purpose The purpose of this study is to assess the performance of the Intent to Attend assessment with regard to its use in a sensitivity analysis of missing data. Methods We fit marginal models to assess whether a patient's self-rated intent predicted actual study adherence. We applied inverse probability of attrition weighting (IPAW) coupled with patient intent to assess whether there existed treatment group differences in response over time. We compared the IPAW results to those obtained using other methods. Results Patient-rated intent predicted missed study visits, even when adjusting for other predictors of missing data. On average, the hazard of retention increased by 19% for every one-point increase in intent. We also found that more severe mania, male gender, and a previously missed visit predicted subsequent absence. Although we found no difference in response between the randomized treatment groups, IPAW increased the estimated group difference over time. Limitations LiTMUS was designed to limit missed study visits, which may have attenuated the effects of adjusting for missing data. Additionally, IPAW can be less efficient and less powerful than maximum likelihood or Bayesian estimators, given that the parametric model is well specified. Conclusions In LiTMUS, the Intent to Attend assessment predicted missed study visits. This item was incorporated into our IPAW models and helped reduce bias due to informative missing data. This analysis should both encourage and facilitate future use of the Intent to Attend assessment along with IPAW to address missing data in a randomized trial.

Original languageEnglish (US)
Pages (from-to)494-502
Number of pages9
JournalClinical Trials
Volume11
Issue number4
DOIs
StatePublished - Aug 2014

ASJC Scopus subject areas

  • Pharmacology

Fingerprint Dive into the research topics of 'A novel application of the Intent to Attend assessment to reduce bias due to missing data in a randomized controlled clinical trial'. Together they form a unique fingerprint.

Cite this